Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05821959 · ClinicalTrials.gov registry record · Phase 1
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
A Phase 1 study of Sensorineural Hearing Loss, Bilateral, sponsored by Akouos.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
- 9
- Study locations
NCT05821959 is a Phase 1 study of Sensorineural Hearing Loss, Bilateral that is actively recruiting participants, run by Akouos. The registered enrollment target is 22 participants, below the 102-participant average among 4 other Sensorineural Hearing Loss, Bilateral trials with a reported enrollment target (78% lower). The trial reports 9 study locations across 9 states.
The verdict
NCT05821959, a Phase 1 study of Sensorineural Hearing Loss, Bilateral, is actively recruiting participants, sponsored by Akouos.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
- 9
- Study locations
Study Summary
Part A of this trial will evaluate the safety and tolerability of a single surgical administration procedure in one or both ear(s) with one of two dose levels of AAVAnc80-hOTOF and will evaluate the Akouos Delivery Device, together with the Precision Delivery Mechanism, to safely achieve the intended product performance.
Conditions Studied
Interventions
- COMBINATION_PRODUCT AAVAnc80-hOTOF via Akouos Delivery Device
- COMBINATION_PRODUCT AAVAnc80-hOTOF via Akouos Delivery Device and Precision Delivery Mechanism
Study Locations (9)
California
- University of California, San Francisco Benioff Children's Hospital - San Francisco
Iowa
- University of Iowa - Iowa City
Massachusetts
- Boston Children's Hospital - Boston
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Tennessee
- Vanderbilt Bill Wilkerson Center - Nashville
Ontario
- The Hospital for Sick Children Jaina.negandhi@sickkids.ca +1 (416) 813 6683 - Toronto
Other
- National Taiwan University Hospital - Taipei
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-09-15 |
| Est. Completion | 2028-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05821959
The ClinicalTrials.gov registry entry for NCT05821959 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 102-participant average among 4 other Sensorineural Hearing Loss, Bilateral trials with a reported enrollment target (78% lower). The listed sponsor is Akouos, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sensorineural Hearing Loss, Bilateral appearing as the primary indexed condition, and to 2 interventions - of which AAVAnc80-hOTOF via Akouos Delivery Device is the first listed.
NCT05821959 reports 9 study locations spanning 9 distinct geographic areas - top geographies include California, Iowa, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05821959 about?
NCT05821959 is a clinical study titled "Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss". Part A of this trial will evaluate the safety and tolerability of a single surgical administration procedure in one or both ear(s) with one of two dose levels of AAVAnc80-hOTOF and will evaluate the Akouos Delivery Device, together with the Precision Delivery Mechanism, to safely achieve the intende...
What is the current status of trial NCT05821959?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2023-09-15. Estimated completion is 2028-10.
What conditions does trial NCT05821959 study?
This clinical trial studies the following conditions: Sensorineural Hearing Loss, Bilateral.
What interventions are being tested in trial NCT05821959?
The interventions under investigation include: AAVAnc80-hOTOF via Akouos Delivery Device (COMBINATION_PRODUCT), AAVAnc80-hOTOF via Akouos Delivery Device and Precision Delivery Mechanism (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05821959?
This trial is sponsored by Akouos, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05821959 being conducted?
This trial has 9 study locations across California, Iowa, Massachusetts, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sensorineural Hearing Loss, Bilateral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Otoferlin Gene-mediated Hearing Loss Natural History Study
RECRUITING
-
Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis
RECRUITING
-
Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant
ACTIVE NOT RECRUITING · NA
-
Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.